BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3185839)

  • 1. Serum sialic acid forms as markers for head and neck malignancies.
    Bhatavdekar JM; Vora HH; Patel DD
    Neoplasma; 1988; 35(4):425-34. PubMed ID: 3185839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of glycoproteins as prognosticators in head and neck malignancy.
    Bathi RJ; Nandimath K; Kannan N; Shetty P
    Indian J Dent Res; 2001; 12(2):93-9. PubMed ID: 11665403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor size-dependent elevations of serum gangliosides in patients with head and neck carcinomas.
    Portoukalian J; David MJ; Shen X; Richard M; Dubreuil C
    Biochem Int; 1989 Apr; 18(4):759-65. PubMed ID: 2764976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer.
    Meyer U; Dierig C; Katopodis N; De Bruijn CH
    Anticancer Res; 1993; 13(5C):1889-94. PubMed ID: 7505544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.
    Molina R; Torres MD; Moragas M; Filella X; Jo J; Giménez N; Traserra J; Ballesta AM
    Anticancer Res; 1995; 15(2):479-84. PubMed ID: 7763026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
    Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
    Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of total and lipid-bound sialic acid in malignancies].
    Cylwik B; Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2005 Aug; 19(110):237-41. PubMed ID: 16245443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
    Gottschlich S; Hoffmann M; Maass JD; Görörgh T; Buhmann V; Hoffmann-Fazel A; Rudert H; Maune S
    Anticancer Res; 2003; 23(2A):913-5. PubMed ID: 12820322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of determining prostate specific antigen in follow-up of prostatic cancer].
    Sadeh AD; Mukamel E; Galili Y; Nussbaum B; Regev D; Servadio C
    Harefuah; 1993 Aug; 125(3-4):69-74, 128. PubMed ID: 7693556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sialic acid levels in various types of cancer.
    Kökoğlu E; Sönmez H; Uslu E; Uslu I
    Cancer Biochem Biophys; 1992 Oct; 13(1):57-64. PubMed ID: 1343847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma.
    Kim CH; Lee JS; Kang SO; Bae JH; Hong SP; Kahng H
    Oral Oncol; 2007 Nov; 43(10):1021-5. PubMed ID: 17306605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sialic acid in the serum--an indicator for malignant growth?].
    Schulze G
    Arch Geschwulstforsch; 1990; 60(1):19-24. PubMed ID: 2310297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum sialic acid bound to lipoproteins. Its contribution to the diagnosis and follow-up of melanoma].
    Sánchez Conejo-Mir J; Sotillo Gago I; Camacho F; Iglesias Huertas R
    Med Cutan Ibero Lat Am; 1990; 18(4):219-23. PubMed ID: 2077306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
    Polívková J; Vosmiková K; Horák L
    Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.